Category: News

After surviving brain cancer, former competitive cyclist Chris Baccash dedicated his life to helping others. Baccash now uses his passion for cycling to make an impact, including by participating in the upcoming Philadelphia Cycling Classic Charity Ride for AACR.

The post Chris Baccash: A Brain Cancer Survivor Who Is Cycling to Make a Difference appeared first on American Association for Cancer Research (AACR).

At the AACR Special Conference on Advances in Malignant Lymphoma, Ronald Levy, MD, FAACR, of Stanford University, discussed how monoclonal antibodies transformed lymphoma treatment; Michel C. Nussenzweig, MD, PhD, of The Rockefeller University, explored affinity and diversity in the antibody response; and conference chair Michael Green, PhD, of The University of Texas MD Anderson Cancer Center, examined epigenetic mechanisms that affect response to targeted therapy.

The post From Discovery to Clinical Impact: AACR Special Conference Captured the Spectrum of Lymphoma Research appeared first on American Association for Cancer Research (AACR).

During the second quarter of 2026, oncology approvals issued by the U.S. Food and Drug Administration expanded the treatment options available for patients with breast cancer, urinary cancers, prostate cancer, rare cancers, and hematologic malignancies. Learn about each new approval and how it fits into the therapeutic landscape.

The post FDA Approvals in Oncology: April-June 2026  appeared first on American Association for Cancer Research (AACR).

The June edition of Editors’ Picks from the AACR journals included studies on targeting neural cross-talk to stop glioblastoma recurrence, identifying patients with multiple myeloma who may benefit from debulking chemotherapy, examining considerable improvements between 1975 and 2020 in survival rates of childhood and adolescent cancer patients, and much more.

The post Editors’ Picks, June 2026: Preventing Colorectal Cancer, Targeting Neural Cross-talk to Stop Glioblastoma Recurrence, and More appeared first on American Association for Cancer Research (AACR).

At the AACR Annual Meeting 2026, a session highlighted progress from four Cancer Grand Challenges teams on the interplay of mutations, promoting factors, and tissue-specific epigenetic programs in cancer development and on the biology of cachexia. Speakers included Michael R. Stratton, MBBS, PhD, FAACR, of the Wellcome Sanger Institute; Allan Balmain, PhD, FAACR, of the University of California, San Francisco; Karen M. Cichowski, PhD, of Harvard Medical School; and Eileen White, PhD, FAACR, of Rutgers University.

The post At the AACR Annual Meeting 2026, Cancer Grand Challenges Teams Explore How Cancer Forms and Evolves appeared first on American Association for Cancer Research (AACR).

The AACR Cancer Disparities Progress Report 2026 included an examination of the growing gap in cancer care between rural and urban areas. The report also featured the stories of several cancer survivors—including Dennis Gruenhagen, Melanie R. Stewart, and Sebastián Casaus Natale—whose care was impacted by geographical barriers.

The post The Long Road to Receiving Care—Examining Cancer Disparities in Rural Areas  appeared first on American Association for Cancer Research (AACR).

The cochairs of the AACR Special Conference on Breaking Barriers in the Fight Against Rare Cancers—Andrew Futreal, PhD, FAACR, of The University of Texas MD Anderson Cancer Center; Taran Gujral, PhD, of Fred Hutch Cancer Center; Brooke E. Howitt, MD, of Stanford University; and Patrick Tan, MD, PhD, of Duke-NUS Medical School in Singapore—shared updates about the current status of rare cancer research and what excites them most about this upcoming meeting.

The post Uncommon Cancers, Common Goals: Overcoming the Challenges of Rare Cancer Research appeared first on American Association for Cancer Research (AACR).

Can AI agents do cancer research? Many AI-centric research teams currently believe that with the right training, AI agents can in fact rise to the level of “co-scientists,” including Jure Leskovec, PhD, of Stanford University, who spoke about designing one of the first generalist biomedical research agents at the AACR Annual Meeting 2026.

The post Eye on AI: Agentic AI Brings Bots to the Bench appeared first on American Association for Cancer Research (AACR).

Chenia Lloyd-Gascho, who was diagnosed with Li-Fraumeni syndrome when he was 8 years old, shared what it is like to grow up knowing you will one day get cancer, the routine monitoring recommended to try to catch cancer early, what happens once you are diagnosed with cancer, and the psychological toll that all this can take on you.

The post What Does It Mean to Be Diagnosed With Li-Fraumeni Syndrome? appeared first on American Association for Cancer Research (AACR).

Melanoma expert Ashani T. Weeraratna, PhD, of Johns Hopkins Bloomberg School of Public Health, explains how bemotrizinol—the first new sunscreen ingredient to be approved by the FDA in over 25 years—compares with currently used ingredients. Weeraratna breaks down how bemotrizinol works, its safety profile, its effectiveness, and more.

The post What to Know About the New FDA-approved Sunscreen Ingredient Bemotrizinol appeared first on American Association for Cancer Research (AACR).